Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ventolin nebulizer with or without 3% hypertonic saline for dyspnea in COPD
IRCT20181205041858N1Phase 2Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of salbutamol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoint: Dyspnea improvement. Started Jan 2019; status: completed.
02
Drugs
salbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20181205041858N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181205041858N1.